Private Equity Roll-Ups in Aesthetics: What Independent Clinic Owners Must Know

Private equity has consolidated roughly 10–15% of US dermatology practices. The med spa market — 90%+ independently owned — is the next frontier. Here is what the numbers actually say, and what every independent clinic owner should understand before an offer arrives.

The Consolidation Wave

Between 2012 and 2018, 17 private-equity-backed groups acquired 184 dermatology practices encompassing approximately 381 clinics, with annual acquisitions climbing from 5 in 2012 to 59 in 2017 [1]. Dermatologists — roughly 1% of US physicians — accounted for 9.9% of all PE physician-group acquisitions in 2013–2016 [1]. By 2022, independent dermatology practice ownership had declined from 62% to 44%, with corporate chains (nearly all PE-backed) accounting for 16% of dermatologists [2].

The med spa market is where the next wave is forming. The US medical aesthetics industry has surpassed USD 17 billion in annual revenue, growing by more than USD 1 billion per year, with 10,488 med spa locations in 2023 — an 18% increase from 8,899 in 2022 [3]. More than 90% remain independently owned [3]. That fragmentation is exactly what PE finds attractive.

The Major Players

As of mid-2026, at least 17 PE-backed dermatology platforms and 5+ PE-backed med spa chains are actively acquiring:

• Advanced Dermatology & Cosmetic Surgery (Harvest Partners) — ~150–180 locations, the largest US dermatology group [4].
• Forefront Dermatology (Partners Group) — 200+ clinics across 22 states [4].
• U.S. Dermatology Partners — lender-controlled since a 2020 loan default; ~90–100 locations across 8 states [4].
• Schweiger Dermatology Group (physician-led with LLR Partners, SV Health, LNK Partners as minority) — 160+ offices [4].
• AQUA Dermatology (Gryphon + GTCR) — 80+ locations across Florida and Georgia [4].
• Platinum Dermatology Partners (Sterling Partners + Sun Capital) — 90+ locations across TX, AZ, NV, CA [4].

In med spa aesthetics specifically: Milan Laser (Leonard Green, 400+ locations), LaserAway (Ares + Seidler, targeting a USD 2B+ valuation in a 2026 sale process per Reuters), SkinSpirit (KKR minority investment), Ideal Image (L Catterton), and Princeton Medspa Partners (Princeton Equity + BC Partners, USD 120M growth financing in 2024) [4, 5].

What the Multiples Actually Look Like

Med spa M&A multiples in 2024–2026, as reported by FOCUS Investment Banking, Skytale Group, BizBuySell, and CT Acquisitions [5]:

Membership revenue share is now the single strongest driver of multiple expansion. Practices with 30–40% of revenue from memberships can add 0.5–1.0x to their multiple versus an otherwise-identical non-membership peer [5].

Typical PE deal structures: 60–80% cash at close, 20–40% rollover equity [5]. Earn-outs tied to EBITDA or membership retention are increasingly common.

The Structure You Need to Understand: MSOs

Because most US states prohibit non-physicians from owning medical practices (the corporate practice of medicine doctrine), PE firms use a Management Services Organization (MSO) structure. The MSO — which PE invests in — owns the business operations, branding, scheduling, marketing, purchasing, and real estate. The physician retains ownership of the clinical professional corporation (PC) through a "friendly PC" model [4].

The practical impact: the PE-backed MSO controls hiring, pricing, scheduling, vendor contracts, and growth strategy — while the physician retains nominal clinical independence. As a 2026 Health Affairs Scholar study notes, PE-owned practices have different utilization patterns than independent practices, and PE-employed physicians are more than 30% less likely to remain with their employer [2, 6].

Why This Matters to Clinic Owners

1. An offer will arrive. With 90%+ of med spas still independent, PE-backed platforms are actively sourcing acquisitions. The question is not whether you will be approached — it is whether you understand what you are being offered.

2. Know what your practice is worth — and what it is not. The 2.1–14.0x multiple range is real, but it is determined by EBITDA (not revenue), membership share, provider dependency, multi-site density, and cash-pay mix. A single-provider practice with owner dependency and no membership program will not command platform-level multiples.

3. Understand what you are giving up. Earn-outs, non-compete clauses, equity rollover, and management agreements can lock you in for 3–7 years with limited operational autonomy. Sellers who engage experienced M&A advisors achieve 23% higher EBITDA multiples on average [7]. Most PE transactions include rollover equity for the "second bite of the apple" — but that equity is only valuable if the platform successfully exits at a higher valuation.

4. Regulatory headwinds are real. States with restrictive corporate practice of medicine doctrines are seeing fewer PE acquisitions [8]. Maryland reported PE ownership in 32.91% of dermatology practices — far above the national average [9]. Know your state's rules before entering discussions.

5. Independent ownership has strategic advantages. The same fragmentation that attracts PE also creates long-term value for independent owners who invest in recurring revenue (memberships), reduce provider dependency, and build multi-location density. You do not have to sell to win.

What We're Watching

• LaserAway's 2026 sale process (targeting USD 2B+ valuation) — a bellwether for med spa platform pricing
• State-level regulatory changes affecting MSO structures and corporate practice of medicine
• Pinnacle Dermatology and QualDerm Partners' reported 2025 combination into a ~158-practice group
• Membership-based revenue models reshaping valuation in PE due diligence
• The declining federal funds rate (3.50–3.75% as of June 2026) lowering PE borrowing costs and accelerating deal volume

About Glowgau

A plug-and-play AI conversion layer for aesthetic and rejuvenation clinics: website, social, chat, and call — no contracts, no software to install, and zero client data held by us (your clinic owns it, always). The AI front desk staff assistant is specialized in your clinic's services, protocols, and details to provide safe, informed responses and convert inquiries into qualified leads 24/7 — not replacing your front desk team, but backing them up after hours and during volume spikes. It chats, talks, and applies a global and Fitzpatrick scale facial assessment that turns inbound curiosity into booked consults. Built by a physician who saw the gap firsthand. What would your conversion rate look like if every inquiry — at any hour — had a clinician-grade intake waiting? glowgau.com

Subscribe to Rejuvenation Medicine Intel for weekly scientific, clinical, and industry updates in rejuvenation and aesthetic medicine — published by Glowgau Intelligence.

References

1. Tan S, Seo Y, Shu X, Huskamp HA, Mainor AJ, Meara JG, Mehrotra A. Trends in Private Equity Acquisition of Dermatology Practices in the United States. JAMA Dermatol. 2019;155(9):1013–1021. PMID: 31339521.
2. Zhang R, White A, Zhang Y, Song Z. Who owns your doctor? A decade of trends in physician practice ownership in dermatology and gastroenterology. Health Aff Scholar. 2026 Jul. PMID: 42524529.
3. American Med Spa Association. 2024 Medical Spa State of the Industry Report. Available from: https://www.americanmedspa.org/blog/amspas-2024-medical-spa-state-of-the-industry-report-shows-medical-aesthetics-continues-steady-growth-after-pandemic
4. DealSeam. Who is buying dermatology practices? PE roll-up tracker (2026). Available from: https://dealseam.com/dermatology-pe-rollup-tracker-2026
5. CT Acquisitions. Med Spa and Medical Aesthetic M&A Multiples Report 2026. July 1, 2026. Available from: https://ctacquisitions.com/guides/med-spa-ma-multiples-2026
6. Zhang R, White A, Song Z, Mehrotra A. Sale of Private Equity-Owned Physician Practices and Physician Turnover. JAMA Health Forum. 2025;6(2):e250045. PMID: 39951313.
7. Aesthetic Brokers. How Private Equity Buys Med Spas, Stage by Stage. October 4, 2025. Available from: https://aestheticbrokers.com/blog/insights-about-private-equity-sales
8. Dermatology Times. Dermatology Market Update 2026: Second Bites, Regulatory Headwinds, and the Flight Toward Scale. 2026. Available from: https://www.dermatologytimes.com/view/dermatology-market-update-2026-second-bites-regulatory-headwinds-and-the-flight-toward-scale
9. Maryland Health Care Commission. Private Equity Investments in Physician Practices in Maryland. Available from: https://mhcc.maryland.gov/sites/default/files/reports/lgst_sb1182_hb1388.pdf